IL17A and rheumatoid arthritis: Nevertheless, the effect of IL-17A or OSM blockade in specific groups of patients with RA, such as those with high levels of IL-17A or OSM in serum or synovial fluid or those with rapidly progressing disease, may be of a high interest.